| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Psychosomatic Medicine, Vol 56, Issue 2 109-117, Copyright © 1994 by American Psychosomatic Society
ORIGINAL ARTICLES |
RM Crum, L Cooper-Patrick and DE Ford
Department of Epidemiology, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland.
Using prospective data from the National Institute of Mental Health (NIMH) Epidemiologic Catchment Area surveys, we examined the relationship of depressive symptoms among patients seen by general medical practitioners, with the subsequent development of major depressive disorder. The goals of the analysis were to determine 1) the 1-year psychiatric status of these individuals, and 2) to evaluate factors associated with the risk of major depressive disorder (MDD) or dysthymia. Between 1980 and 1984, collaborators of the NIMH Epidemiologic Catchment Area program recruited 18,571 adult participants after probability sampling of census tracts and households in five metropolitan areas. To assess the occurrence of psychiatric conditions over time, staff administered the Diagnostic Interview Schedule soon after sampling and again at follow-up 1 year later. For this analysis, the study sample was limited to respondents who reported seeing a general medical physician in the previous 6 months and who were free of current depressive disorder at the baseline interview. Overall, 41% of the general medical patients reported experiencing at least one depressive symptom in the past 6 months. Between 3 and 5% of the individuals with depressive symptoms developed MDD or dysthymia at the follow-up interview. Although individuals with depressed mood had a slightly higher estimated relative risk compared with individuals with vegetative, or nonvegetative (cognitive) depressive symptoms, no single classification of symptoms was appreciably more likely to signal MDD or dysthymia 1 year later. However, the risk of depression increased with the number of depressive symptoms reported.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
D. V. Iosifescu, A. A. Nierenberg, J. E. Alpert, M. Smith, S. Bitran, C. Dording, and M. Fava The Impact of Medical Comorbidity on Acute Treatment in Major Depressive Disorder Focus, January 1, 2005; 3(1): 69 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Iosifescu, A. A. Nierenberg, J. E. Alpert, G. I. Papakostas, R. H. Perlis, S. Sonawalla, and M. Fava Comorbid Medical Illness and Relapse of Major Depressive Disorder in the Continuation Phase of Treatment Psychosomatics, October 1, 2004; 45(5): 419 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Perlis, D. V. Iosifescu, J. Alpert, A. A. Nierenberg, J. F. Rosenbaum, and M. Fava Effect of Medical Comorbidity on Response to Fluoxetine Augmentation or Dose Increase in Outpatients With Treatment-Resistant Depression Psychosomatics, June 1, 2004; 45(3): 224 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Golden, J. E. Williams, D. E. Ford, H.-C. Yeh, C. Paton Sanford, F. J. Nieto, and F. L. Brancati Depressive Symptoms and the Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities study Diabetes Care, February 1, 2004; 27(2): 429 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Iosifescu, A. A. Nierenberg, J. E. Alpert, M. Smith, S. Bitran, C. Dording, and M. Fava The Impact of Medical Comorbidity on Acute Treatment in Major Depressive Disorder Am J Psychiatry, December 1, 2003; 160(12): 2122 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Kwon, Y.-M. Kim, C.-G. Chang, B.-J. Park, L. Kim, D. J. Yoon, W.-S. Han, H.-J. Lee, and I. K. Lyoo Three-Year Follow-Up of Women With the Sole Diagnosis of Depressive Personality Disorder: Subsequent Development of Dysthymia and Major Depression Am J Psychiatry, December 1, 2000; 157(12): 1966 - 1972. [Abstract] [Full Text] |
||||
![]() |
C. G. Lyketsos, F. Taragano, G. J. Treisman, and J. Paz Major Depression and Its Response to Sertraline in Primary Care vs. Psychiatric Office Practice Patients: Results of an Open-Label Trial in Argentina Psychosomatics, February 1, 1999; 40(1): 70 - 75. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |